(Q40534566)

21 September 2017

title

The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa (English)

1 reference

21 September 2017

0 references

0 references

1 reference

hepatocellular carcinoma

1 reference

7

Pierre Hainaut

1 reference

21 September 2017

1

Gregory D Kirk

1 reference

21 September 2017

6

James J Goedert

1 reference

21 September 2017

10

Ruggero Montesano

1 reference

21 September 2017

9

Hilton Whittle

1 reference

21 September 2017

Olufunmilayo A Lesi

2

1 reference

21 September 2017

Maimuna Mendy

3

1 reference

21 September 2017

Aliu O Akano

4

1 reference

21 September 2017

Omar Sam

5

1 reference

21 September 2017

Andrew J Hall

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

39

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

211-219

1 reference

Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma

21 September 2017

cites work

1 reference

Cancer burden in the year 2000. The global picture

21 January 2018

1 reference

7 January 2021

Hepatitis B and C viruses in the development of hepatocellular carcinoma

1 reference

7 January 2021

Extrahepatic manifestations of hepatitis C among United States male veterans

1 reference

7 January 2021

Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe

1 reference

7 January 2021

The influence of age on the development of the hepatitis B carrier state

1 reference

7 January 2021

Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994

1 reference

7 January 2021

The injection century: massive unsterile injections and the emergence of human pathogens

1 reference

7 January 2021

Epidemiology of hepatitis C: geographic differences and temporal trends

1 reference

7 January 2021

Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa

1 reference

7 January 2021

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

1 reference

7 January 2021

A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma

1 reference

7 January 2021

Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area

1 reference

7 January 2021

The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks

1 reference

7 January 2021

Cancer in the Gambia: 1988-97.

1 reference

7 January 2021

The pattern of childhood hepatitis B infection in two Gambian villages

1 reference

7 January 2021

Risk factors for transmission of hepatitis B virus to Gambian children

1 reference

7 January 2021

Hepatitis B virus infection in two Gambian villages

1 reference

7 January 2021

Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis.

1 reference

7 January 2021

Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas

1 reference

7 January 2021

Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma

1 reference

7 January 2021

The dynamics of hepatitis B virus infection

1 reference

7 January 2021

Natural history of hepatitis C

1 reference

7 January 2021

Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma

1 reference

7 January 2021

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

1 reference

7 January 2021

Hepatitis B e antigen and the risk of hepatocellular carcinoma

1 reference

7 January 2021

High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis

1 reference

7 January 2021

Clinical significance of hepatitis B virus genotypes

1 reference

7 January 2021

Prevalence of HBV core promoter/precore/core mutations in Gambian chronic carriers

1 reference

7 January 2021

Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice

1 reference

7 January 2021

Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection

1 reference

7 January 2021

Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis

1 reference

7 January 2021

The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men

1 reference

7 January 2021

High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.

1 reference

7 January 2021

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

1 reference

7 January 2021

Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

1 reference

7 January 2021

Characteristics of patients with dual infection by hepatitis B and C viruses

1 reference

7 January 2021

Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

1 reference

7 January 2021

Persistent hepatitis B virus infection and hepatoma in The Gambia, west Africa. A case-control study of 140 adults and their 603 family contacts

1 reference

7 January 2021

Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age

1 reference

7 January 2021

1 reference

7 January 2021

Global programme for control of hepatitis B infection

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20027

1 reference

21 September 2017

1 reference